162 related articles for article (PubMed ID: 18562401)
1. The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX.
Wilffert B; Al Hadithy AF; Sing VJ; Matroos G; Hoek HW; van Os J; Bruggeman R; Brouwers JR; van Harten PN
J Psychopharmacol; 2009 Aug; 23(6):652-9. PubMed ID: 18562401
[TBL] [Abstract][Full Text] [Related]
2. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
Al Hadithy AF; Ivanova SA; Pechlivanoglou P; Semke A; Fedorenko O; Kornetova E; Ryadovaya L; Brouwers JR; Wilffert B; Bruggeman R; Loonen AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):475-81. PubMed ID: 19439249
[TBL] [Abstract][Full Text] [Related]
3. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
Gunes A; Scordo MG; Jaanson P; Dahl ML
Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
[TBL] [Abstract][Full Text] [Related]
7. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
[TBL] [Abstract][Full Text] [Related]
8. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
Gunes A; Melkersson KI; Scordo MG; Dahl ML
J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors.
Al Hadithy AF; Wilffert B; Stewart RE; Looman NM; Bruggeman R; Brouwers JR; Matroos GE; van Os J; Hoek HW; van Harten PN
Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):890-7. PubMed ID: 18389501
[TBL] [Abstract][Full Text] [Related]
10. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.
Segman RH; Heresco-Levy U; Finkel B; Inbar R; Neeman T; Schlafman M; Dorevitch A; Yakir A; Lerner A; Goltser T; Shelevoy A; Lerer B
Psychopharmacology (Berl); 2000 Nov; 152(4):408-13. PubMed ID: 11140333
[TBL] [Abstract][Full Text] [Related]
11. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ
Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179
[TBL] [Abstract][Full Text] [Related]
12. Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients.
Gunes A; Dahl ML; Spina E; Scordo MG
Eur J Clin Pharmacol; 2008 May; 64(5):477-82. PubMed ID: 18205001
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia.
Chong SA; Tan EC; Tan CH; Mythily ; Chan YH
Am J Med Genet B Neuropsychiatr Genet; 2003 Jan; 116B(1):51-4. PubMed ID: 12497614
[TBL] [Abstract][Full Text] [Related]
14. Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment.
Lattuada E; Cavallaro R; Serretti A; Lorenzi C; Smeraldi E
Int J Neuropsychopharmacol; 2004 Dec; 7(4):489-93. PubMed ID: 15383158
[TBL] [Abstract][Full Text] [Related]
15. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
Zai CC; Hwang RW; De Luca V; Müller DJ; King N; Zai GC; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
Int J Neuropsychopharmacol; 2007 Oct; 10(5):639-51. PubMed ID: 16959057
[TBL] [Abstract][Full Text] [Related]
16. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.
Basile VS; Masellis M; Badri F; Paterson AD; Meltzer HY; Lieberman JA; Potkin SG; Macciardi F; Kennedy JL
Neuropsychopharmacology; 1999 Jul; 21(1):17-27. PubMed ID: 10379516
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.
Steen VM; Løvlie R; MacEwan T; McCreadie RG
Mol Psychiatry; 1997 Mar; 2(2):139-45. PubMed ID: 9106238
[TBL] [Abstract][Full Text] [Related]
18. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.
Lerer B; Segman RH; Tan EC; Basile VS; Cavallaro R; Aschauer HN; Strous R; Chong SA; Heresco-Levy U; Verga M; Scharfetter J; Meltzer HY; Kennedy JL; Macciardi F
Int J Neuropsychopharmacol; 2005 Sep; 8(3):411-25. PubMed ID: 15857569
[TBL] [Abstract][Full Text] [Related]
19. Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population.
Boke O; Gunes S; Kara N; Aker S; Sahin AR; Basar Y; Bagci H
DNA Cell Biol; 2007 Aug; 26(8):527-31. PubMed ID: 17688403
[TBL] [Abstract][Full Text] [Related]
20. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
